Free Trial

Annex Advisory Services LLC Has $1.22 Million Stake in Balchem Co. (NASDAQ:BCPC)

Balchem logo with Basic Materials background

Annex Advisory Services LLC increased its stake in Balchem Co. (NASDAQ:BCPC - Free Report) by 35.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,496 shares of the basic materials company's stock after purchasing an additional 1,959 shares during the period. Annex Advisory Services LLC's holdings in Balchem were worth $1,222,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Inspire Investing LLC grew its position in Balchem by 2.7% in the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company's stock valued at $413,000 after purchasing an additional 62 shares in the last quarter. Hsbc Holdings PLC increased its position in shares of Balchem by 1.5% in the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company's stock valued at $757,000 after acquiring an additional 75 shares during the last quarter. Atomi Financial Group Inc. raised its holdings in Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company's stock worth $295,000 after acquiring an additional 96 shares in the last quarter. Xponance Inc. boosted its position in Balchem by 5.2% during the second quarter. Xponance Inc. now owns 2,046 shares of the basic materials company's stock valued at $315,000 after purchasing an additional 102 shares during the last quarter. Finally, Heritage Family Offices LLP grew its stake in Balchem by 8.3% in the fourth quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company's stock valued at $231,000 after purchasing an additional 109 shares in the last quarter. Institutional investors own 87.91% of the company's stock.

Balchem Stock Performance

BCPC traded up $2.88 during trading hours on Tuesday, reaching $163.03. The company's stock had a trading volume of 128,366 shares, compared to its average volume of 128,630. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The company's 50-day moving average is $169.87 and its 200-day moving average is $170.95. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The firm has a market cap of $5.30 billion, a PE ratio of 43.83, a price-to-earnings-growth ratio of 4.31 and a beta of 0.69.

Balchem Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were issued a $0.87 dividend. This is a boost from Balchem's previous annual dividend of $0.79. This represents a yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. Balchem's dividend payout ratio is currently 23.39%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on BCPC. HC Wainwright raised their target price on shares of Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research note on Monday, November 4th. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a report on Monday, October 28th.

Get Our Latest Stock Report on BCPC

Balchem Company Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Read More

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines